Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

← catalyst calendar

NCT06097260 · results posted

Sponsored by Pliant Therapeutics, Inc. (industry) · PLRX — their whole pipeline →.

Phase
Phase 2
Status
Terminated
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
320actual
Sites
268
Countries
Argentina, Australia, Belgium +22

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Why the sponsor stopped it

DSMB recommendation

As filed on the registry record, in the sponsor's own words.

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-11-16actualWhen the study began enrolling
Primary completion2025-04-04actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-04-04actualThe whole study's end, after follow-up
First posted2023-10-24actualWhen this record first appeared on the registry
Results posted2026-08-05actualWhen the sponsor posted results to the registry
Record updated2026-08-05actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Idiopathic Pulmonary Fibrosis

Interventions

  • Drug: PLN-74809
  • Drug: Placebo

Primary outcome

what the primary-completion date above is the date OF
Change From Baseline in Forced Vital Capacity at Week 52
measured Baseline (Day 1) and Week 52

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol: v2.22_EUposted 2024-06-05 · 3.0 MB · Prot_001.pdf
Study Protocol: v1.2posted 2024-06-04 · 2.5 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-04-02 · 2.2 MB · SAP_002.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · PLRX's whole pipeline · Catalyst calendar · Every registered study · What changed